BSECompany Update1d ago · 28 Oct 2026, 02:58 pm
Press release - For the Second quarter and half year ended on September 30, 2026
Concord Biotech Ltd · 543960
✦ AI SummaryResults
Concord Biotech Ltd has announced its unaudited standalone and consolidated financial results for the second quarter and half year ended on September 30, 2026. The company has also published a notice regarding the loss of share certificates and the issue of duplicate share certificates.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper Publication